Marker Therapeutics, Inc. Common Stock (MRKR) is a publicly traded Healthcare sector company. As of May 21, 2026, MRKR trades at $1.38 with a market cap of $23.18M and a P/E ratio of -2.33. MRKR moved +2.16% today. Year to date, MRKR is -21.23%; over the trailing twelve months it is +23.68%. Its 52-week range spans $0.81 to $5.95. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces MRKR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Marker Therapeutics, Inc. Common Stock (MRKR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MRKR moved +2.16% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.38 |
| Market Cap | $23.18M |
| P/E Ratio | -2.33 |
| EPS | $-0.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.95 |
| 52-Week Low | $0.81 |
| Volume | 433 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.95M |
| Net Income | $-10.90M |
| Gross Margin | 0.00% |
2 analysts cover MRKR: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.